ReviewCureus2025
Risk Factor Analysis for Vascular Occlusions After Dermal Filler Injections: A Systematic Review and Meta-Analysis.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This systematic review and meta-analysis investigate the risk factors associated with vascular occlusions following dermal filler injections, a rare but serious complication in aesthetic medicine. Fourteen studies involving various filler materials and injection sites were analyzed to identify patient and procedural variables influencing clinical outcomes. The most frequently used filler was hyaluronic acid (HA) (61.3%), and most complications occurred in female patients (71%). Anatomical regions with complex vasculature, such as the glabella, nose, and nasolabial folds, were most commonly implicated. Recovery outcomes were significantly influenced by the specific vessels involved, with occlusions in smaller arteries showing a better prognosis. Timely recognition and intervention were associated with improved recovery, with delays beyond five days correlating with permanent deficits. Hyaluronidase use in HA-related occlusions yielded high partial or total recovery rates with an 84.2% success rate, reaffirming its role as a first-line treatment. Based on the analysis, a morbidity risk assessment tool was developed to stratify patients into low-, moderate-, and high-risk categories, offering practical value for clinical decision-making. The findings underscore the importance of anatomical precision, prompt intervention, and standardized treatment protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.